Pullman-based Schweitzer takes autism detection tool to clinical trial
The Pullman-based company announced the launch of a clinical trial for its first medical device, which detects atypical reactions to light in a child's pupils.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Seattle Times; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories

Why it mattersA massive fire broke at a vacant hotel in Hollywood overnight, prompting a response from around 150 firefighters.

Why it mattersDHS Secretary Markwayne Mullin will be in the hotseat in Congress Wednesday, following last week's air ground stop and several outages of critical online services.

Why it mattersWhat if? Mamdani questioned over replacing NYPD with civilians on protest front lines

Why it mattersTeen suspect in Bronx killing of Javits Frimpong before school to be tried as an adult: DA